-
April 12, 2021 Psychedelics Company Atai Adds Brain-Computer Interface for Mental Health TreatmentAtai Life Sciences is working to combine psychedelics with brain-computer interfaces for mental health treatment.
-
April 9, 2021 Psychedelic Business News Spotlight: April 9, 2021This week in psychedelic business news: a psilocybin delivery system for brain inflammation, a genetic...
-
April 9, 2021 The Company of Others: How Shared Psychedelic Experiences Influence OutcomesDoes taking psychedelics with others improve the experiences for all individuals? Researchers are looking at...
-
April 8, 2021 Psychedelic Conference to Explore Promising Therapies for Veterans, First RespondersThe Heroic Dose conference will explore the use of psychedelic therapies to treat post-traumatic stress...
-
April 8, 2021 Mydecine Prepares to Present Four Novel Psychedelic CandidatesColorado-based Mydecine is launching four new psychedelic candidates for use in treating conditions like anxiety...
-
April 7, 2021 Yale to Study Psilocybin for Cluster HeadachesPsilocybin is showing relief as treatment for cluster headaches — a painful condition that affects...
-
April 6, 2021 Study Investigates Optimal Dosing for MDMAPotential optimal MDMA dosages for therapeutic benefit and reduced adverse events were investigated in a...
-
April 5, 2021 How the Benefits Microdosing Psychedelics Compare to YogaNew research looks at the benefits of microdosing psychedelics on wellness compared with regular yoga...
-
April 2, 2021 Psychedelic Business News Spotlight: April 2, 2021This week in psychedelic business news: cannabis dives in, ketamine delivery, and psilocybin for autism...
-
April 1, 2021 How Field Trip Health Is Leading the Psychedelic Market BoomField Trip Health is brining psychedelics to the forefront of mental health wellness.
